These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 12134624)

  • 1. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
    Buée L; Bussière T; Buée-Scherrer V; Delacourte A; Hof PR
    Brain Res Brain Res Rev; 2000 Aug; 33(1):95-130. PubMed ID: 10967355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau protein as a differential biomarker of tauopathies.
    Sergeant N; Delacourte A; Buée L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
    Schraen-Maschke S; Dhaenens CM; Delacourte A; Sablonnière B
    Neurobiol Dis; 2004 Apr; 15(3):449-60. PubMed ID: 15056452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].
    Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T
    No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein].
    Delisle MB; Uro-Coste E; Murrell JR; Rascol O; Ghetti B
    Bull Acad Natl Med; 2000; 184(4):799-809; discussion 809-11. PubMed ID: 10989564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single molecule profiling of tau gene expression in Alzheimer's disease.
    Conrad C; Zhu J; Conrad C; Schoenfeld D; Fang Z; Ingelsson M; Stamm S; Church G; Hyman BT
    J Neurochem; 2007 Nov; 103(3):1228-36. PubMed ID: 17727636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau phosphorylation in neuronal cell function and dysfunction.
    Johnson GV; Stoothoff WH
    J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR; Lang AE
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
    Hasegawa M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
    Paquet D; Schmid B; Haass C
    Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microtubule-associated protein tau in development, degeneration and protection of neurons.
    Wang JZ; Liu F
    Prog Neurobiol; 2008 Jun; 85(2):148-75. PubMed ID: 18448228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.